Approval · Notice of Compliance 1237 · 2000
ORUVAIL: Notice of Compliance 1237
Issued November 30, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1237
- Date
- November 30, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-inflammatory angalgesic agent
Products in this notice
Medicinal ingredients
- KETOPROFEN 150 MG per CAP
- KETOPROFEN 200 MG per CAP